Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy aims to shrink lung cancer recurrence

NCT ID NCT06771518

Recruiting now Disease control Sponsor: Regina Elena Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 07, 2026 · Last updated Jun 11, 2026 · Updated 1 time

Summary

This study tests whether adding chest radiation to maintenance immunotherapy (atezolizumab) can reduce the chance of cancer returning in the chest for people with extensive-stage small cell lung cancer. About 37 adults whose cancer has shrunk after initial chemo-immunotherapy will receive radiation alongside continued atezolizumab. The goal is to see if this combination keeps the cancer under control better than immunotherapy alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • "Regina Elena" National Cancer Institute

    RECRUITING

    Rome, Rome, 00144, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SMALL CELL LUNG CANCER

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

EXTENSIVE-STAGE SMALL-CELL LUNG CANCER